<DOC>
	<DOC>NCT02535442</DOC>
	<brief_summary>The objective of this study is to evaluate the microbial consortia and the host inflammatory factors present in the nasal passages of patients during upper respiratory symptomology and when healthy using culture and molecular analysis techniques.</brief_summary>
	<brief_title>Nasal Swab Study to Explore the Nasal Microbia</brief_title>
	<detailed_description />
	<mesh_term>Common Cold</mesh_term>
	<criteria>Adults, male or female, between the ages 18 60 Exhibiting symptoms of an upper respiratory ailment, which may include runny or stuffy nose, sore throat, fever, headache, cough, malaise, or loss of appetite with no indication or intention to treat with excluded medications. Use of antibiotics, antifungals, antivirals, antihistamines, anticholinergic, antiinflammatory, any nasal inhaled medications (other than saline), or steroid medications within the four (4) weeks prior to enrollment and during the course of the study. Use of cough suppressants and herbal medications are permitted.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>